These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

569 related items for PubMed ID: 19185400

  • 1. The effect of combined calcium and vitamin D3 supplementation on serum intact parathyroid hormone in moderate CKD.
    Kooienga L, Fried L, Scragg R, Kendrick J, Smits G, Chonchol M.
    Am J Kidney Dis; 2009 Mar; 53(3):408-16. PubMed ID: 19185400
    [Abstract] [Full Text] [Related]

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 3. Clinical and laboratory safety of one year's use of a combination calcium + vitamin D tablet in ambulatory elderly women with vitamin D insufficiency: results of a multicenter, randomized, double-blind, placebo-controlled study.
    Brazier M, Grados F, Kamel S, Mathieu M, Morel A, Maamer M, Sebert JL, Fardellone P.
    Clin Ther; 2005 Dec; 27(12):1885-93. PubMed ID: 16507374
    [Abstract] [Full Text] [Related]

  • 4. Prevalence of vitamin D [25(OH)D] deficiency and effects of supplementation with ergocalciferol (vitamin D2) in stage 5 chronic kidney disease patients.
    Blair D, Byham-Gray L, Lewis E, McCaffrey S.
    J Ren Nutr; 2008 Jul; 18(4):375-82. PubMed ID: 18558303
    [Abstract] [Full Text] [Related]

  • 5. A randomized, double-blind, placebo-controlled study to assess the efficacy and safety of cinacalcet HCl in participants with CKD not receiving dialysis.
    Chonchol M, Locatelli F, Abboud HE, Charytan C, de Francisco AL, Jolly S, Kaplan M, Roger SD, Sarkar S, Albizem MB, Mix TC, Kubo Y, Block GA.
    Am J Kidney Dis; 2009 Feb; 53(2):197-207. PubMed ID: 19110359
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of a new solid formulation of calcium and vitamin D in institutionalized elderly subjects. A randomized comparative trial versus separate administration of both constituents.
    Sebert JL, Garabedian M, Chauvenet M, Maamer M, Agbomson F, Brazier M.
    Rev Rhum Engl Ed; 1995 Apr; 62(4):288-94. PubMed ID: 7606425
    [Abstract] [Full Text] [Related]

  • 7. Intravenous paricalcitol for treatment of secondary hyperparathyroidism in children on hemodialysis.
    Greenbaum LA, Benador N, Goldstein SL, Paredes A, Melnick JZ, Mattingly S, Amdahl M, Williams LA, Salusky IB.
    Am J Kidney Dis; 2007 Jun; 49(6):814-23. PubMed ID: 17533024
    [Abstract] [Full Text] [Related]

  • 8. Treatment of vitamin D deficiency increases lower limb muscle strength in institutionalized older people independently of regular physical activity: a randomized double-blind controlled trial.
    Moreira-Pfrimer LD, Pedrosa MA, Teixeira L, Lazaretti-Castro M.
    Ann Nutr Metab; 2009 Jun; 54(4):291-300. PubMed ID: 19729890
    [Abstract] [Full Text] [Related]

  • 9. Longitudinal assessment of estimated glomerular filtration rate in apparently healthy adults: a post hoc analysis from the JUPITER study (justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin).
    Vidt DG, Ridker PM, Monyak JT, Schreiber MJ, Cressman MD.
    Clin Ther; 2011 Jun; 33(6):717-25. PubMed ID: 21704236
    [Abstract] [Full Text] [Related]

  • 10. Oral paricalcitol for the treatment of secondary hyperparathyroidism in patients on hemodialysis or peritoneal dialysis.
    Ross EA, Tian J, Abboud H, Hippensteel R, Melnick JZ, Pradhan RS, Williams LA, Hamm LL, Sprague SM.
    Am J Nephrol; 2008 Jun; 28(1):97-106. PubMed ID: 17914251
    [Abstract] [Full Text] [Related]

  • 11. Variability and risk factors for kidney disease progression and death following attainment of stage 4 CKD in a referred cohort.
    Levin A, Djurdjev O, Beaulieu M, Er L.
    Am J Kidney Dis; 2008 Oct; 52(4):661-71. PubMed ID: 18805347
    [Abstract] [Full Text] [Related]

  • 12. Paricalcitol capsule for the treatment of secondary hyperparathyroidism in stages 3 and 4 CKD.
    Coyne D, Acharya M, Qiu P, Abboud H, Batlle D, Rosansky S, Fadem S, Levine B, Williams L, Andress DL, Sprague SM.
    Am J Kidney Dis; 2006 Feb; 47(2):263-76. PubMed ID: 16431255
    [Abstract] [Full Text] [Related]

  • 13. Calcium and vitamin D3 supplements in calcium and vitamin D3 sufficient early postmenopausal healthy women.
    Tfelt-Hansen J, Tørring O.
    Eur J Clin Nutr; 2004 Oct; 58(10):1420-4. PubMed ID: 15114377
    [Abstract] [Full Text] [Related]

  • 14. Percent true calcium absorption, mineral metabolism, and bone mass in children with arthritis: effect of supplementation with vitamin D3 and calcium.
    Hillman LS, Cassidy JT, Chanetsa F, Hewett JE, Higgins BJ, Robertson JD.
    Arthritis Rheum; 2008 Oct; 58(10):3255-63. PubMed ID: 18821668
    [Abstract] [Full Text] [Related]

  • 15. Effects of long-term cholecalciferol supplementation on mineral metabolism and calciotropic hormones in chronic kidney disease.
    Oksa A, Spustová V, Krivosíková Z, Gazdíková K, Fedelesová V, Lajdová I, Stefíková K, Bernasovská G, Zilinská Z, Dzúrik R.
    Kidney Blood Press Res; 2008 Oct; 31(5):322-9. PubMed ID: 18802363
    [Abstract] [Full Text] [Related]

  • 16. Influence of daily calcium and vitamin D supplementation on parathyroid hormone secretion.
    Reginster JY, Zegels B, Lejeune E, Micheletti MC, Taquet AN, Albert A.
    Gynecol Endocrinol; 2001 Feb; 15(1):56-62. PubMed ID: 11293926
    [Abstract] [Full Text] [Related]

  • 17. Vitamin D insufficiency and treatment with oral vitamin D3 in children with chronic kidney disease.
    Kari JA, Eldesoky SM, Bagdadi OT.
    Saudi Med J; 2012 Jul; 33(7):740-4. PubMed ID: 22821307
    [Abstract] [Full Text] [Related]

  • 18. Inadequate dietary calcium and vitamin D intakes in renal-transplant recipients in Ireland.
    Lynch IT, Eustace JA, Plant WD, Cashman KD, O'Keefe M, Lordan S, Moloney R.
    J Ren Nutr; 2007 Nov; 17(6):408-15. PubMed ID: 17971313
    [Abstract] [Full Text] [Related]

  • 19. Impact of ergocalciferol treatment of vitamin D deficiency on serum parathyroid hormone concentrations in chronic kidney disease.
    Zisman AL, Hristova M, Ho LT, Sprague SM.
    Am J Nephrol; 2007 Nov; 27(1):36-43. PubMed ID: 17215573
    [Abstract] [Full Text] [Related]

  • 20. Secondary hyperparathyroidism in primary osteoporosis and osteopenia: optimizing calcium and vitamin D intakes to levels recommended by expert panels may not be sufficient for correction.
    Yendt ER, Kovacs KA, Jones G.
    Clin Endocrinol (Oxf); 2008 Dec; 69(6):855-63. PubMed ID: 18419790
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.